0001225208-21-006981.txt : 20210423
0001225208-21-006981.hdr.sgml : 20210423
20210423212439
ACCESSION NUMBER: 0001225208-21-006981
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210423
FILED AS OF DATE: 20210423
DATE AS OF CHANGE: 20210423
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: STONE HEISZ LESLIE
CENTRAL INDEX KEY: 0001235408
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-15525
FILM NUMBER: 21851196
MAIL ADDRESS:
STREET 1: C/O PUBLIC STORAGE
STREET 2: 701 WESTERN AVENUE
CITY: GLENDALE
STATE: CA
ZIP: 91201
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Edwards Lifesciences Corp
CENTRAL INDEX KEY: 0001099800
STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
IRS NUMBER: 364316614
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE EDWARDS WAY
CITY: IRVINE
STATE: CA
ZIP: 92614
BUSINESS PHONE: 9492502500
MAIL ADDRESS:
STREET 1: ONE EDWARDS WAY
CITY: IRVINE
STATE: CA
ZIP: 92614
FORMER COMPANY:
FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP.
DATE OF NAME CHANGE: 20090225
FORMER COMPANY:
FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP
DATE OF NAME CHANGE: 20000203
FORMER COMPANY:
FORMER CONFORMED NAME: CVG CONTROLLED INC
DATE OF NAME CHANGE: 19991126
4
1
doc4.xml
X0306
4
2021-04-23
0001099800
Edwards Lifesciences Corp
EW
0001235408
STONE HEISZ LESLIE
ONE EDWARDS WAY
IRVINE
CA
92614
1
Common Stock
2021-04-23
4
M
0
10000.0000
35.6767
A
29272.0000
D
Common Stock
2021-04-23
4
S
0
6707.0000
97.5200
D
22565.0000
D
Director Stock Option (Right to Acquire)
35.6767
2021-04-23
4
M
0
10000.0000
0.0000
D
2017-07-14
2023-07-13
Common Stock
10000.0000
9671.0000
D
The Issuer requires that upon vesting or exercise of equity awarded after 2011, each director is required to hold the underlying common stock (net of any shares sold to cover the exercise price and applicable taxes) until the director's Board service ends. These shares underlying the options exercised were sold to cover the exercise price and applicable taxes.
On May 29, 2020, the common stock of the Issuer split 3-for-1, resulting in the Reporting Person's ownership of additional shares of common stock and stock options. This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.
Linda J. Park, Attorney-in-Fact
2021-04-23